Description
CA 15-3
Cancer Antigen 15-3 (CA 15-3) is a tumor marker for breast cancer. It is derived from MUC1 and considered to be one of the first circulating prognostic factors for breast cancer. It is often used to monitor the response of breast cancer treatment and to watch for breast cancer recurrence. It may also give a sense of how much cancer is present (tumor burden).
Additional Information
Method: |
Enzyme Immunoassay, Chemiluminescence |
Principle: |
Sandwich Assay, Streptavidin-Coated Plate |
Calibrators: |
0, 10, 40, 100, 200, 400 U/ml |
Sample: |
25 µl |
Sensitivity: |
0.2 U/ml |
Reading: |
RLU’s |
Total Time: |
95 Minutes |
Shelf Life: |
18 Months |
Related Products
CA-125 AccuLite CLIA Kit
Monobind
€473.80 - €590.00
CA 125
Cancer Antigen 125 (CA 125) is a protein often found on the surface of ovarian cancer cells and in some normal tissues. It is one of the protein antigens that have been associated with the...
CA 19-9 AccuLite CLIA Kit
Monobind
€646.00 - €842.00
CA 19-9
Cancer Antigen 19-9 (CA 19-9) is a protein that exists on the surface of certain cells. CA 19-9 does not cause cancer; rather, it is a protein that is shed by the tumor cells, making it...
PRL AccuLite CLIA Kit
Monobind
€356.20 - €552.20
PRL
Prolactin (PRL) is a hormone produced by the anterior pituitary gland, a grape-sized organ found at the base of the brain. Prolactin levels are regulated by dopamine (a brain chemical), and...
DHEA AccuLite CLIA Kit
Monobind
€588.60 - €1,017.00
DHEA
5-Dehydroepiandrosterone (5-DHEA) is an endogenous naturalsteroid hormone secreted by the adrenal glands. DHEA is also produced by the gonads andthe brain making it the most abundant...